Transcriptional associations of osteoarthritis-mediated loss of epigenetic control in articular cartilage

Arthritis and Rheumatology

Volumn 67, Issue 8, 2015, Pages 2108-2116

  Den Hollander, Wouter ^a   Ramos, Yolande F M ^a   Bomer, Nils ^a   Elzinga, Stefan ^a   Van Der Breggen, Ruud ^a   Lakenberg, Nico ^a   De Dijcker, Wesley J ^a   Suchiman, H Eka D ^a   Duijnisveld, Bouke J ^a   Houwing Duistermaat, Jeanine J ^a   Slagboom, P Eline ^a,b   Bos, Steffan D ^a,b   Nelissen, Rob G H H ^a   Meulenbelt, Ingrid ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Netherlands Genomics Initiative   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COL6A3 PROTEIN; DYSF PROTEIN; HEPATOCYTE NUCLEAR FACTOR 3BETA; IGFBP7 PROTEIN; PROTEIN; TRANSCRIPTION FACTOR DLX5; TRANSCRIPTION FACTOR RUNX1; UACA PROTEIN; UNCLASSIFIED DRUG; TRANSCRIPTOME;

ARTICLE; ARTICULAR CARTILAGE; CONTROLLED STUDY; DNA METHYLATION; ENCHONDRAL OSSIFICATION; EPIGENETICS; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; OSTEOARTHRITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; CPG ISLAND; FEMALE; GENETIC EPIGENESIS; GENETICS; MALE; METABOLISM;

CARTILAGE, ARTICULAR; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HUMANS; MALE; OSTEOARTHRITIS; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTOME;

EID: 84938150955     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39162     Document Type: Article

References (42)

1. Bijlsma JW, Berenbaum F, Lafeber FP., Osteoarthritis: an update with relevance for clinical practice. Lancet 2011; 377: 2115-26.
2. Loeser RF, Goldring SR, Scanzello CR, Goldring MB., Osteoarthritis: a disease of the joint as an organ [review]. Arthritis Rheum 2012; 64: 1697-707.
3. Chen YA, Lemire M, Choufani S, Butcher DT, Grafodatskaya D, Zanke BW, et al., Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics 2013; 8: 203-9.
4. Dvir-Ginzberg M, Reich E., Chopping off the chondrocyte proteome. Biomarkers 2014; 1-7. E-pub ahead of print.
5. Sun MM, Beier F., Chondrocyte hypertrophy in skeletal development, growth, and disease. Birth Defects Res C Embryo Today 2014; 102: 74-82.
6. Hosaka Y, Saito T, Sugita S, Hikata T, Kobayashi H, Fukai A, et al., Notch signaling in chondrocytes modulates endochondral ossification and osteoarthritis development. Proc Natl Acad Sci U S A 2013; 110: 1875-80.
7. Laurent L, Wong E, Li G, Huynh T, Tsirigos A, Ong CT, et al., Dynamic changes in the human methylome during differentiation. Genome Res 2010; 20: 320-31.
8. Slieker RC, Bos SD, Goeman JJ, Bovee JV, Talens RP, van der Breggen R, et al., Identification and systematic annotation of tissue-specific differentially methylated regions using the Illumina 450k array. Epigenetics Chromatin 2013; 6: 26.
9. Rushton MD, Reynard LN, Barter MJ, Refaie R, Rankin KS, Young DA, et al., Characterization of the cartilage DNA methylome in knee and hip osteoarthritis. Arthritis Rheumatol 2014; 66: 2450-60.
10. Den Hollander W, Ramos YF, Bos SD, Bomer N, van der Breggen R, Lakenberg N, et al., Knee and hip articular cartilage have distinct epigenomic landscapes: implications for future cartilage regeneration approaches. Ann Rheum Dis 2014; 73: 2208-12.
11. Jeffries MA, Donica M, Baker LW, Stevenson ME, Annan AC, Humphrey MB, et al., Genome-wide DNA methylation study identifies significant epigenomic changes in osteoarthritic cartilage. Arthritis Rheumatol 2014; 66: 2804-15.
12. Fernandez-Tajes J, Soto-Hermida A, Vazquez-Mosquera ME, Cortes-Pereira E, Mosquera A, Fernandez-Moreno M, et al., Genome-wide DNA methylation analysis of articular chondrocytes reveals a cluster of osteoarthritic patients. Ann Rheum Dis 2014; 73: 668-77.
13. Bell JT, Pai AA, Pickrell JK, Gaffney DJ, Pique-Regi R, Degner JF, et al., DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines [published erratum appears in Genome Biol 2011; 12: 405 ]. Genome Biol 2011;12:R10.
14. Bomer N, den Hollander W, Ramos YF, Bos SD, van der Breggen R, Lakenberg N, et al., Underlying molecular mechanisms of DIO2 susceptibility in symptomatic osteoarthritis. Ann Rheum Dis 2014. E-pub ahead of print.
15. Reynard LN, Bui C, Syddall CM, Loughlin J., CpG methylation regulates allelic expression of GDF5 by modulating binding of SP1 and SP3 repressor proteins to the osteoarthritis susceptibility SNP rs143383. Hum Genet 2014; 133: 1059-73.
16. Hashimoto K, Oreffo RO, Gibson MB, Goldring MB, Roach HI., DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytes. Arthritis Rheum 2009; 60: 3303-13.
17. Hashimoto K, Otero M, Imagawa K, de Andres MC, Coico JM, Roach HI, et al., Regulated transcription of human matrix metalloproteinase 13 (MMP13) and interleukin-1β (IL1B) genes in chondrocytes depends on methylation of specific proximal promoter CpG sites. J Biol Chem 2013; 288: 10061-72.
18. Ramos YF, den Hollander W, Bovee JV, Bomer N, van der Breggen R, Lakenberg N, et al., Genes involved in the osteoarthritis process identified through genome wide expression analysis in articular cartilage; the RAAK Study. PLoS One 2014; 9: e103056.
19. Schoenmaker M, de Craen AJ, de Meijer PH, Beekman M, Blauw GJ, Slagboom PE, et al., Evidence of genetic enrichment for exceptional survival using a family approach: the Leiden Longevity Study. Eur J Hum Genet 2006; 14: 79-84.
20. Ramos YF, Metrustry S, Arden N, Bay-Jensen AC, Beekman M, de Craen AJ, et al., Meta-analysis identifies loci affecting levels of the potential osteoarthritis biomarkers sCOMP and uCTX-II with genome wide significance. J Med Genet 2014; 51: 596-604.
21. Wood AR, Esko T, Yang J, Vedantam S, Pers TH, Gustafsson S, et al., Defining the role of common variation in the genomic and biological architecture of adult human height. Nat Genet 2014; 46: 1173-86.
22. Douglas Bates D, Martin Maechler M, Ben Bolker B., lme4: linear mixed-effects models using S4 classes. R package version 0.9999-l/r1692. 2012. URL: http://cran.r-project.org/web/packages/lme4/index.html.
23. arcOGEN Consortium, arcOGEN Collaborators. Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study. Lancet 2012; 380: 815-23.
24. Bos SD, Slagboom PE, Meulenbelt I., New insights into osteoarthritis: early developmental features of an ageing-related disease. Curr Opin Rheumatol 2008; 20: 553-9.
25. Pullig O, Weseloh G, Swoboda B., Expression of type VI collagen in normal and osteoarthritic human cartilage. Osteoarthritis Cartilage 1999; 7: 191-202.
26. Soder S, Hambach L, Lissner R, Kirchner T, Aigner T., Ultrastructural localization of type VI collagen in normal adult and osteoarthritic human articular cartilage. Osteoarthritis Cartilage 2002; 10: 464-70.
27. Wilson R, Norris EL, Brachvogel B, Angelucci C, Zivkovic S, Gordon L, et al., Changes in the chondrocyte and extracellular matrix proteome during post-natal mouse cartilage development. Mol Cell Proteomics 2012; 11: M111.014159.
28. Manabe R, Tsutsui K, Yamada T, Kimura M, Nakano I, Shimono C, et al., Transcriptome-based systematic identification of extracellular matrix proteins. Proc Natl Acad Sci U S A 2008; 105: 12849-54.
29. DeChiara TM, Kimble RB, Poueymirou WT, Rojas J, Masiakowski P, Valenzuela DM, et al., Ror2, encoding a receptor-like tyrosine kinase, is required for cartilage and growth plate development. Nat Genet 2000; 24: 271-4.
30. Ermakov S, Trofimov S, Malkin I, Livshits G., A significant association exists between receptor tyrosine kinase-like orphan receptor 2 gene variants and the OPG/RANKL ratio in human plasma. Osteoporos Int 2012; 23: 1899-907.
31. Ramos YF, Bos SD, van der Breggen R, Kloppenburg M, Ye K, Lameijer EW, et al., A gain of function mutation in TNFRSF11B encoding osteoprotegerin causes osteoarthritis with chondrocalcinosis. Ann Rheum Dis 2014. E-pub ahead of print.
32. Liu Y, Bhat RA, Seestaller-Wehr LM, Fukayama S, Mangine A, Moran RA, et al., The orphan receptor tyrosine kinase Ror2 promotes osteoblast differentiation and enhances ex vivo bone formation. Mol Endocrinol 2007; 21: 376-87.
33. Kruger C, Kappen C., Expression of cartilage developmental genes in Hoxc8- and Hoxd4-transgenic mice. PLoS One 2010; 5: e8978.
34. Castano Betancourt MC, Cailotto F, Kerkhof HJ, Cornelis FM, Doherty SA, Hart DJ, et al., Genome-wide association and functional studies identify the DOT1L gene to be involved in cartilage thickness and hip osteoarthritis. Proc Natl Acad Sci U S A 2012; 109: 8218-23.
35. Leijten JC, Emons J, Sticht C, van Gool S, Decker E, Uitterlinden A, et al., Gremlin 1, frizzled-related protein, and Dkk-1 are key regulators of human articular cartilage homeostasis. Arthritis Rheum 2012; 64: 3302-12.
36. Lories RJ, Corr M, Lane NE., To Wnt or not to Wnt: the bone and joint health dilemma. Nat Rev Rheumatol 2013; 9: 328-39.
37. Ford CE, Qian Ma SS, Quadir A, Ward RL., The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesis. Int J Cancer 2013; 133: 779-87.
38. Fukuyo S, Yamaoka K, Sonomoto K, Oshita K, Okada Y, Saito K, et al., IL-6-accelerated calcification by induction of ROR2 in human adipose tissue-derived mesenchymal stem cells is STAT3 dependent. Rheumatology (Oxford) 2014; 53: 1282-90.
39. Lu C, Wan Y, Cao J, Zhu X, Yu J, Zhou R, et al., Wnt-mediated reciprocal regulation between cartilage and bone development during endochondral ossification. Bone 2013; 53: 566-74.
40. Wang LT, Wang SJ, Hsu SH., Functional characterization of mammalian Wntless homolog in mammalian system. Kaohsiung J Med Sci 2012; 28: 355-61.
41. Evangelou E, Chapman K, Meulenbelt I, Karassa FB, Loughlin J, Carr A, et al., Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand. Arthritis Rheum 2009; 60: 1710-21.
42. Loughlin J, Dowling B, Chapman K, Marcelline L, Mustafa Z, Southam L, et al., Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females. Proc Natl Acad Sci U S A 2004; 101: 9757-62.